The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy and safety of apatinib combined with paclitaxel and carboplatin dose-dense regimen in neoadjuvant therapy for locally advanced triple-negative breast cancer.
 
Qiao Li
No Relationships to Disclose
 
Jiaxuan Liu
No Relationships to Disclose
 
Pin Zhang
No Relationships to Disclose
 
Fei Ma
No Relationships to Disclose
 
Yang Luo
No Relationships to Disclose
 
Peng Yuan
No Relationships to Disclose
 
Jiayu Wang
No Relationships to Disclose
 
Kaiping Ou
No Relationships to Disclose
 
Xin Wang
No Relationships to Disclose
 
Liqiang Qi
No Relationships to Disclose
 
Yipeng Wang
No Relationships to Disclose
 
Maiyue He
No Relationships to Disclose
 
Jianhong Lv
No Relationships to Disclose
 
Yang Yang
No Relationships to Disclose
 
Binghe Xu
Speakers' Bureau - AstraZeneca; Eisai; Pfizer; Roche
Research Funding - Jiangsu Hengrui Medicine (Inst)